Charles River 18. Mai 2026 Drug Development Inputs & Services Stocks Q1 In Review: Charles River Laboratories (NYSE:CRL) Vs Peers - StockStory
Mettler Toledo 18. Mai 2026 Mettler-Toledo stock (US5926881054): solid Q1 2026 growth keeps focus on margin and automation - AD HOC NEWS
Mettler Toledo 18. Mai 2026 How Investors Are Reacting To Mettler-Toledo International (MTD) Q1 Beat And 2026 Sales Growth Outlook - simplywall.st
Bio-Rad 18. Mai 2026 How Investors Are Reacting To Bio-Rad Laboratories (BIO) As RBC Sees Margin Upside Under New Leadership - simplywall.st
Charles River 18. Mai 2026 Charles River Laboratories stock (US1591881009): Q1 results, guidance and what matters for investors - AD HOC NEWS
GCC 18. Mai 2026 GCC Hydroxypropyl Methylcellulose Market Report 2026–2034 | Construction and Pharma Trends - vocal.media
Amgen 18. Mai 2026 Høeg fired in latest FDA shakeup; 20 people die after taking Amgen drug - BioPharma Dive
Bio-Rad 18. Mai 2026 Elliott builds big stake in life-science firm Bio-Rad Labs, WSJ reports (BIO:NYSE) - Seeking Alpha
Edwards Lifesciences 18. Mai 2026 Edwards Lifesciences stock (US28176E1082): heart valve specialist in focus after recent results - AD HOC NEWS
Bio-Rad 18. Mai 2026 Elliott builds big stake in life-science tools supplier Bio-Rad Labs, WSJ reports - KSLM Radio
Vertex 18. Mai 2026 Vertex Pharma stock (US92532F1003): focus on cystic fibrosis and expanding pipeline - AD HOC NEWS
10x Genomics News 18. Mai 2026 Assessing 10x Genomics (TXG) Valuation After Q1 2026 Results And Rising AI Trading Interest - simplywall.st
Amgen 18. Mai 2026 Amgen Inc. stock (US0311621009): earnings beat, dividend and guidance keep biotech giant in focus - AD HOC NEWS